NORBATRIN

This brand name is authorized in Nigeria.

Active ingredients

The drug NORBATRIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Neomycin UNII I16QD7X297 - NEOMYCIN
	Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
	Read more about Neomycin
2	Bacitracin UNII 89Y4M234ES - BACITRACIN ZINC
	Read more about Bacitracin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100745	Powder	NORBATRIN POWDER 10GM PWD 250IU; 3300UNITS 1 X 10gm	21 NF-PP-338920 NORBATRIN POWDER 10GM BACITRACIN ZINC BP 250IU, NEOMYCIN SULPHATE BP 3300UNITS BACITRACIN ZINC BP 250IU, NEOMYCIN SULPHATE BP 3300UNITS, STARCH (SANITISED) A4-100745 Drugs Imported Products 110GM OTC 7/3/2023 NORBARC PHARMACEUTICAL LIMITED, NO. 7 ABEOKUTA STREET EBUTE META 7036535830 norbarcpharm@yahoo.com MARINE LIFE SCIENCES., PLOT NO.30 PHASE III (EXT) HPSIDC, BADDI DSTT. SOLAN (H.P) INDIA, India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07AA51	Neomycin, combinations	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100745